These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12450764)

  • 1. Can the premises of the altered homeostatic theory permit improvement in the prevention of ischemic heart disease?
    Hellstrom HR
    Med Hypotheses; 2003 Jan; 60(1):12-25. PubMed ID: 12450764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the premises of the spasm of resistance vessel concept permit improvement in the treatment and prevention of ischemic heart disease?
    Hellstrom HR
    Med Hypotheses; 2003 Jan; 60(1):36-51. PubMed ID: 12450766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occlusions of epicardial arteries might not directly induce symptoms in ischemic heart disease.
    Hellstrom HR
    Med Hypotheses; 1999 Dec; 53(6):533-42. PubMed ID: 10687898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence in support of the spasm of resistance vessel concept of ischemic heart disease: an update in 1993.
    Hellstrom HR
    Med Hypotheses; 1993 Jul; 41(1):11-22. PubMed ID: 8231973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol: an important but relatively overemphasized risk factor for ischemic heart disease.
    Hellstrom HR
    Med Hypotheses; 2001 Nov; 57(5):593-601. PubMed ID: 11735317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The altered homeostatic theory: a holistic approach to multiple diseases, including atherosclerosis, ischemic diseases, and hypertension.
    Hellstrom HR
    Med Hypotheses; 1999 Sep; 53(3):194-9. PubMed ID: 10580523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
    Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
    Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
    Varbo A; Benn M; Nordestgaard BG
    Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
    Law MR; Wald NJ; Rudnicka AR
    BMJ; 2003 Jun; 326(7404):1423. PubMed ID: 12829554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors.
    Gil-Núñez AC; Villanueva JA
    Cerebrovasc Dis; 2001; 11 Suppl 1():85-95. PubMed ID: 11244205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of various electrophoretic characteristics of LDL particles and their relationship to the risk of ischemic heart disease.
    St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Bernard PM; Després JP; Lamarche B
    Circulation; 2001 Nov; 104(19):2295-9. PubMed ID: 11696468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
    Sepanlou SG; Farzadfar F; Jafari E; Danaei G
    Arch Iran Med; 2012 Sep; 15(9):531-7. PubMed ID: 22924369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remnant cholesterol and ischemic heart disease.
    Varbo A; Nordestgaard BG
    Curr Opin Lipidol; 2014 Aug; 25(4):266-73. PubMed ID: 24977981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New evidence for the spasm-of-resistance-vessel concept of ischemic diseases.
    Hellstrom HR
    Med Hypotheses; 1999 Sep; 53(3):200-9. PubMed ID: 10580524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
    Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
    Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expanding role of HMG-CoA reductase inhibitors (statins) in the prevention and treatment of ischemic heart disease.
    Chilton R; O'Rourke RA
    Curr Probl Cardiol; 2001 Dec; 26(12):734-64. PubMed ID: 11743453
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigating pleiotropic effects of statins on ischemic heart disease in the UK Biobank using Mendelian randomisation.
    Schooling CM; Zhao JV; Au Yeung SL; Leung GM
    Elife; 2020 Aug; 9():. PubMed ID: 32838838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease.
    Lamarche B; Tchernof A; Mauriège P; Cantin B; Dagenais GR; Lupien PJ; Després JP
    JAMA; 1998 Jun; 279(24):1955-61. PubMed ID: 9643858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.